John F Crowley Amicus Therapeutics, Inc. (FOLD) insider trading activity

John F Crowley is Executive Chairman of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 573,478 shares of FOLD, which is worth approximately $5.6 Million. The most recent transaction as insider was on Feb 22, 2021, when has been sold 7,682 shares (Common Stock) at a price of $11.98 per share, resulting in proceeds of $92,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K

0% 3M change

37.14% 12M change

Total Value Held $5.6 Million

John F Crowley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2021	SELL Open market or private sale	$92,030 $11.98 p/Share	7,682 Reduced 0.9%	844,206 Common Stock
Feb 16 2021	SELL Open market or private sale	$269,720 $12.26 p/Share	22,000 Reduced 2.52%	851,888 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$141,900 $6.45 p/Share	22,000 Added 2.46%	873,888 Common Stock
Feb 01 2021	SELL Open market or private sale	$143,100 $19.08 p/Share	7,500 Reduced 0.87%	851,888 Common Stock
Jan 20 2021	SELL Open market or private sale	$1,075,500 $21.51 p/Share	50,000 Reduced 5.5%	859,388 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$690,319 $21.84 p/Share	31,608 Reduced 3.36%	909,388 Common Stock
Jan 15 2021	SELL Open market or private sale	$489,280 $22.24 p/Share	22,000 Reduced 2.36%	909,388 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	80,327 Added 7.86%	940,996 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$141,900 $6.45 p/Share	22,000 Added 2.31%	931,388 Common Stock
Jan 04 2021	SELL Open market or private sale	$166,275 $22.17 p/Share	7,500 Reduced 1.0%	745,429 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	115,240 Added 11.81%	860,669 Common Stock
Jan 03 2021	SELL Payment of exercise price or tax liability	$461,661 $23.09 p/Share	19,994 Reduced 2.59%	752,929 Common Stock
Jan 02 2021	SELL Payment of exercise price or tax liability	$530,331 $23.09 p/Share	22,968 Reduced 2.89%	772,923 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$261,725 $23.09 p/Share	11,335 Reduced 1.4%	795,891 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$376,067 $23.09 p/Share	16,287 Reduced 1.98%	807,226 Common Stock
Dec 15 2020	SELL Open market or private sale	$526,020 $23.91 p/Share	22,000 Reduced 2.6%	823,513 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$141,900 $6.45 p/Share	22,000 Added 2.54%	845,513 Common Stock
Dec 01 2020	SELL Open market or private sale	$170,775 $22.77 p/Share	7,500 Reduced 0.9%	823,513 Common Stock
Nov 02 2020	SELL Open market or private sale	$605,346 $17.87 p/Share	33,875 Reduced 3.92%	831,013 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$142,891 $5.96 p/Share	23,975 Added 2.7%	864,888 Common Stock
Oct 01 2020	SELL Open market or private sale	$419,198 $14.02 p/Share	29,900 Reduced 3.43%	840,913 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$119,200 $5.96 p/Share	20,000 Added 2.25%	870,813 Common Stock

Also insider at

NTLA

Intellia Therapeutics, Inc. Healthcare

Director

TRDA

Entrada Therapeutics, Inc. Healthcare

Director

JFC

John F Crowley

Executive Chairman

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account